Details checkedClinical trial listing onlyCheckedtrial

Cochlear Population Mean Mapping Strategy

Also known as: Population mean mapping, Cochlear population mean mapping

Cochlear

Primary source

Company

Cochlear

Program Type

Software/Neurotech

Modality

Cochlear/Auditory Implant

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

External cochlear implant programming workflow

Confidence

82%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

United States

Population

adult, cochlear-implant, post-implant-programming

Trial IDs

Mechanism

Cochlear implant programming workflow using population mean mapping to reduce activation/programming burden while maintaining speech perception outcomes.

Indications

Hearing Loss Sensorineural Hearing Loss

Notes

Verified as an active cochlear-implant programming strategy study, not a standalone implant or therapeutic product. It should remain visible as workflow/software evidence and rank below product-level marketed or clinical development programs.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, company, allCompanies, stage, status, mechanism, indications, populationTags...

IDs: NCT06960616

Open

Key Events

2025-02-10

ClinicalTrials.gov posted population mean mapping strategy study

Clinical Trials (1)

NCT06960616

Data Checks